Zobrazeno 1 - 10
of 3 459
pro vyhledávání: '"Hematologic Malignancy"'
Autor:
Wenxiu Shu, Qianqian Yang, Jing Le, Qianqian Cai, Hui Dai, Liufei Luo, Jiaqi Tong, Yanping Song, Bingrong Chen, Yaodong Tang, Dian Jin
Publikováno v:
European Journal of Medical Research, Vol 29, Iss 1, Pp 1-9 (2024)
Abstract Background Coinfections in patients with coronavirus disease 2019 (COVID-19) affect patient prognosis. Patients with hematologic malignancies (HMs) are usually immunosuppressed and may be at high risk of coinfection, but few related data hav
Externí odkaz:
https://doaj.org/article/bf60e381163a415696e88295c9365621
Publikováno v:
Shanghai Jiaotong Daxue xuebao. Yixue ban, Vol 44, Iss 11, Pp 1460-1465 (2024)
Mucin-type O-glycosylation is one of the most common post-translational modifications in proteins, capable of altering protein conformation and biological functions. It plays a crucial role in biological processes such as cell signaling, cell adhesio
Externí odkaz:
https://doaj.org/article/e05c69aaebb344afaa7085f50054690a
Publikováno v:
Current Oncology, Vol 31, Iss 11, Pp 7117-7128 (2024)
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a clinically aggressive hematologic malignancy derived from plasmacytoid dendritic cells. It commonly presents as cutaneous lesions. To date, no standard treatment protocol for BPDCN exists. Tra
Externí odkaz:
https://doaj.org/article/d32e87f83a9d4fc6aeb6e148afa43994
Autor:
Chaoting Zhang, Ting Liu, Shance Li, Xia Teng, Yuge Zhu, Guanyu Zhang, Huimin Xie, Kang Sun, Jiaxin Tu, Wenjun Yang, Zheming Lu
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-6 (2024)
Abstract Enhancing the efficacy of CD19 CAR-T cell therapy can significantly improve patient outcomes by reducing relapse rates in CD19 + B cell malignancies. Exogenous or transgenic cytokines are often used to boost the expansion and durability of C
Externí odkaz:
https://doaj.org/article/83f839168cd84edbb25365849d15419f
Autor:
Li Ye, Ye Yang, Xuewu Zhang, Lu Wang, Li Zhu, Xia Li, Yile Zhou, Xiaolong Zheng, Xinping Zhou, Yanling Ren, Liya Ma, Gaixiang Xu, Chunmei Yang, Huafeng Wang, De Zhou, Min Yang, Xingnong Ye, Juying Wei, Wenjuan Yu, Jiejing Qian, Yinjun Lou, Wanzhuo Xie, Jian Huang, Haitao Meng, Jie Jin, Hongyan Tong
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Purpose The essence of this scholarly work was to carefully outline the key factors intensifying the virulence and protracted contagion of COVID-19, particularly among individuals afflicted with hematologic malignancies (HM), in an epoch pre
Externí odkaz:
https://doaj.org/article/6c19244eca03404d9f80f551944d54e1
Autor:
Yuan-dong Feng, Jin Du, Hong-li Chen, Ying Shen, Ya-chun Jia, Peng-yu Zhang, Aili He, Yun Yang
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-21 (2024)
Abstract Hematological malignancies are a group of cancers that affect the blood, bone marrow, and lymphatic system. Cancer stem cells (CSCs) are believed to be responsible for the initiation, progression, and relapse of hematological malignancies. H
Externí odkaz:
https://doaj.org/article/bcbb4d6be6b4452a8630a120c7823fcf
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-26 (2024)
Abstract Due to spatial and genomic independence, mitochondria possess a translational mechanism distinct from that of cytoplasmic translation. Several regulators participate in the modulation of mitochondrial translation. Mitochondrial translation i
Externí odkaz:
https://doaj.org/article/3ab741565df740ecaeaa0b3daf823355
Publikováno v:
Journal of Research in Pharmacy Practice, Vol 12, Iss 4, Pp 115-122 (2024)
Objective: This cross-sectional study aimed to assess the frequency of potential drug–drug interactions (DDIs) and demographic correlates of moderate and major DDIs among patients with hematologic cancer at a referral hematology hospital in Iran. M
Externí odkaz:
https://doaj.org/article/f1d567dc19cb427f880bf9f5bd6f84ac
Autor:
Sevil Sadri, Burcu Tunay
Publikováno v:
The Egyptian Journal of Internal Medicine, Vol 36, Iss 1, Pp 1-8 (2024)
Abstract Background The Hemoglobin, Albumin, Lymphocyte, Platelet Score (HALP) is a novel predictive biomarker that has surfaced in the literature in recent years. It has been applied to the prediction of many clinical outcomes related to different n
Externí odkaz:
https://doaj.org/article/89848d3dc3724de3ab50234117089300
